Author: Minghua Jiang; Wenjie Fang; Amir Aratehfar; Xiaojing Li; Liyan ling; Hua Fang; Farnaz Farnaz Daneshnia; Jian Yu; Wanqing Liao; Hao Pei; Weihua Pan; Cornelia Lass-Florl
Title: Development and validation of a rapid single-step reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) system potentially to be used for reliable and high-throughput screening of COVID-19 Document date: 2020_3_20
ID: eo2pcgix_9
Snippet: Analytical sensitivity and specificity testing was performed in a P2 lab and in order to mimic the real 90 viral particles we purchased pseudotyped SARS-CoV-2 assay system containing ORF1ab part 91 sequence, N gene and E gene (DAAN gene Co. Ltd, Guangzhou, China). RNA of pseudotyped virus 92 were extracted using EZ-10 Spin Column Viral Total RNA Extraction Kit (Sangon Biotech Co.,Ltd. 93 Shanghai, China). Serial dilutions with the magnitude of lo.....
Document: Analytical sensitivity and specificity testing was performed in a P2 lab and in order to mimic the real 90 viral particles we purchased pseudotyped SARS-CoV-2 assay system containing ORF1ab part 91 sequence, N gene and E gene (DAAN gene Co. Ltd, Guangzhou, China). RNA of pseudotyped virus 92 were extracted using EZ-10 Spin Column Viral Total RNA Extraction Kit (Sangon Biotech Co.,Ltd. 93 Shanghai, China). Serial dilutions with the magnitude of log10 containing 50*10 6 cell/ml to 50*10 0 94 cell/ml pseudotyped virus were performed to determine the limit of detection (LOD). Serial dilution 95 testing was performed in both RNase/DNase free molecular grade water and sputum sample collected 96 from a COVID-19 negative healthy individual. Reproducibility of our LAMP assay (linearity=R 2 97 value) was assessed by separate serial dilution testing on three occasions, each performed in duplicate. 98 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- pseudotype virus and SARS assay: 1, 2, 3, 4, 5, 6, 7, 8
- pseudotype virus and SARS assay system: 1
- pseudotype virus and viral particle: 1
- pseudotyped virus and SARS assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- pseudotyped virus and SARS assay system: 1
- pseudotyped virus and viral particle: 1, 2, 3
- SARS assay and serial dilution: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- SARS assay and specificity testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- SARS assay and viral particle: 1, 2, 3, 4, 5, 6
- serial dilution and specificity testing: 1
- serial dilution and viral particle: 1
Co phrase search for related documents, hyperlinks ordered by date